Simcere Pharmaceutical Group Ltd
HKEX:2096

Watchlist Manager
Simcere Pharmaceutical Group Ltd Logo
Simcere Pharmaceutical Group Ltd
HKEX:2096
Watchlist
Price: 11.02 HKD -5.97% Market Closed
Market Cap: 27.4B HKD

Intrinsic Value

The intrinsic value of one Simcere Pharmaceutical Group Ltd stock under the Base Case scenario is 11.91 HKD. Compared to the current market price of 11.02 HKD, Simcere Pharmaceutical Group Ltd is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
11.91 HKD
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Simcere Pharmaceutical Group Ltd

Compare Simcere Pharmaceutical Group Ltd to

Fundamental Analysis

Simcere Pharmaceutical Group Ltd
HKEX:2096
CN
Pharmaceuticals
Market Cap
27.4B HKD
IPO
Oct 27, 2020
CN
Pharmaceuticals
Market Cap
27.4B HKD
IPO
Oct 27, 2020
Price
HK$false
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Simcere Pharmaceutical Group Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Simcere Pharmaceutical Group Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Simcere Pharmaceutical Group Ltd

Balance Sheet Decomposition
Simcere Pharmaceutical Group Ltd

Current Assets 5.5B
Cash & Short-Term Investments 1.9B
Receivables 2.8B
Other Current Assets 758.2m
Non-Current Assets 6B
Long-Term Investments 1.9B
PP&E 2.3B
Intangibles 1.2B
Other Non-Current Assets 713.9m
Efficiency

Free Cash Flow Analysis
Simcere Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Simcere Pharmaceutical Group Ltd

Revenue
6.6B CNY
Cost of Revenue
-1.3B CNY
Gross Profit
5.3B CNY
Operating Expenses
-4.2B CNY
Operating Income
1.1B CNY
Other Expenses
-402.6m CNY
Net Income
733.2m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Simcere Pharmaceutical Group Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROE
Healthy Operating Margin
54/100
Profitability
Score

Simcere Pharmaceutical Group Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Simcere Pharmaceutical Group Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency
81/100
Solvency
Score

Simcere Pharmaceutical Group Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Simcere Pharmaceutical Group Ltd

Wall Street analysts forecast Simcere Pharmaceutical Group Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Simcere Pharmaceutical Group Ltd is 10.24 HKD with a low forecast of 7.68 HKD and a high forecast of 15.02 HKD.

Lowest
Price Target
7.68 HKD
30% Downside
Average
Price Target
10.24 HKD
7% Downside
Highest
Price Target
15.02 HKD
36% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Simcere Pharmaceutical Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Simcere Pharmaceutical Group Ltd stock?

The intrinsic value of one Simcere Pharmaceutical Group Ltd stock under the Base Case scenario is 11.91 HKD.

Is Simcere Pharmaceutical Group Ltd stock undervalued or overvalued?

Compared to the current market price of 11.02 HKD, Simcere Pharmaceutical Group Ltd is Undervalued by 7%.

Back to Top